Sort
50,496 grants matching “lung cancer”
In-patient hospice and rapid autopsy to interrogate tumor heterogeneity
$399,554Udayan Guha · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Platelet Serine/Threonine Phosphatases in Cancer Pathophysiology
$399,554K. Vinod Vijayan · Baylor College Of Medicine · R01 · FY2024 · CA
Clinical Protocols in the Cancer Signaling Networks Section
$399,554Udayan Guha · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Cigarette Smoking among American Indian Women Experiencing Intimate Partner Violence
$399,542Patricia Nez Henderson · Black Hills Ctr/American Indian Health · S06 · FY2018 · GM
Project 1: Effects of unventilated filters on pattern of cigarette use, toxicant exposure and uptake of alternative nicotine products
$399,540Dorothy K Hatsukami · University Of Minnesota · P01 · FY2017 · CA
Core B: Biomarker and Constituent Core
$399,539Irina Stepanov · University Of Minnesota · P01 · FY2017 · CA
Genetic Determinants of Oxygen Toxicity
$399,517Valeria C Culotta · Johns Hopkins University · R37 · FY2011 · GM
Development of Programmable mRNA Circuits for Melanoma Immunotherapy
$399,508Ryan Sowell · Strand Therapeutics Inc · R43 · FY2021 · CA
An innovative telomerase-targeted, circulating tumor cell assay for monitoring NSCLC treated with radiation and immunotherapy
$399,499Deeksha Saxena · Liquid Biodx Llc · R43 · FY2023 · CA
Reposition and Optimization of Deferiprone for Breast Cancer Therapy
$399,479Adegboyega Oyelere · Georgia Institute Of Technology · R01 · FY2025 · CA
Mechanisms and Modulators of Sensitivity and Resistance to EGFR Inhibitors in Lu
$399,448William Pao · Sloan-Kettering Inst Can Research · P01 · FY2012 · CA
SOUTHWEST ONCOLOGY GROUP
$399,443Swedish Medical Center, First Hill · U10 · FY2002 · CA
Novel Anti-CCR8 VHH for the Treatment of NSCLC
$399,424Mauro Mileni · Abilita Bio, Inc. · R43 · FY2023 · CA
Identification of Resistance Mechanisms to Anaplastic Lymphoma Kinase Inhibitors
$399,380Alice T Shaw · Massachusetts General Hospital · R01 · FY2018 · CA
Identification of Resistance Mechanisms to Anaplastic Lymphoma Kinase Inhibitors
$399,380Jessica Jiyeong Lin · Massachusetts General Hospital · R01 · FY2021 · CA
Identification of Resistance Mechanisms to Anaplastic Lymphoma Kinase Inhibitors
$399,380Jessica Jiyeong Lin · Massachusetts General Hospital · R01 · FY2020 · CA
Identification of Resistance Mechanisms to Anaplastic Lymphoma Kinase Inhibitors
$399,380Alice T Shaw · Massachusetts General Hospital · R01 · FY2017 · CA
Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma
$399,356Roberto Chiarle · Boston Children'S Hospital · R01 · FY2024 · CA
Development of a Novel Therapeutic Transporter to Treat Metastatic Cancers
$399,346Richard L. Klemke · Cytonus Therapeutics, Inc. · R41 · FY2020 · CA
Augmenting focused ultrasound-mediated drug delivery to brain tumors with vascular normalization
$399,294Richard J Price · University Of Virginia · R21 · FY2024 · CA
Activation and Regulation of the Understudied Kinome Using MIB/MS Technology
$399,282Gary L. Johnson · Univ Of North Carolina Chapel Hill · U01 · FY2014 · MH
Training Grant in Lung Cell and Molecular Biology
$399,249Benjamin D Medoff · Massachusetts General Hospital · T32 · FY2010 · HL
Engineering therapeutic and diagnostic proteins for tumor biomarker mesothelin
$399,232Sarah J. Moore · Smith College · R15 · FY2015 · CA
c-Myc modulation and its implications in EGFR-targeted cancer therapy
$399,207Shi-Yong Sun · Emory University · R01 · FY2020 · CA
Shifting the immune infiltrates in osteosarcoma lung metastases with locally targeted CSF-1Ris for combination therapies
$399,187Sandro R. P. Da Rocha · Virginia Commonwealth University · R21 · FY2021 · CA